AngioDynamics expects full-year results to range from a loss of 33 cents per share to a loss of 23 cents per share, with revenue in the range of $308 million to $313 million. AngioDynamics shares have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback